The Latest Cardiac and Vascular News
Funds Support Further Development of V-Wave Implantable Interatrial Cardiac Shunt for Heart Failure and Pulmonary Hypertension CAESAREA, Israel and AGOURA HILLS, Calif., Sept. 22, 2020 /PRNewswire/ — V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension (PAH), announced […]
TEL AVIV, Israel, Sept. 23, 2020 (GLOBE NEWSWIRE) — OnSight Medical, a leading AI ultrasound company specializing in cardiology, today announced Rick Heinick will be joining its Board of Directors. Mr. Heinick is a recognized healthcare entrepreneur, who founded the ophthalmic pharmaceutical company TearClear, serving as its Executive Chairman for […]
Key appointment forms part of Creavo’s strategy to scale the Company Creavo’s Corsens® technology developed to improve patient care pathway in cardiac diagnostics COVENTRY, England–(BUSINESS WIRE)–Creavo Medical Technologies Ltd (Creavo), the medical device company developing innovative diagnostics techniques, has announced that it has appointed Martin Frost as Chairman of the […]
The Company Appoints New President and CEO ALISO VIEJO, Calif., Sept. 22, 2020 /PRNewswire/ — MicroVention, Inc., a U.S. based subsidiary of Terumo and leading global neurovascular company, announced today the appointment of a new President and CEO, Mr. Carsten Schroeder. The MicroVention acting President and CEO, Kazuaki Kitabatake, who has been in his […]
MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of Lisa Giles and Robert Wills to its Board of Directors, effective October 1, 2020. Ms. Giles will serve as a member of the Audit Committee of the Board and Dr. […]
Novel perfusion monitoring system injects new precision into the treatment of peripheral artery disease and critical limb ischemia SINGAPORE, Sept. 22, 2020 /PRNewswire/ — PEDRA™ Technology, a Singapore-based developer of innovative deep-tissue perfusion monitors, today announced the completion of $4.7M Series A financing, with investors including SEEDS Capital, the investment arm of Enterprise Singapore, M&L Healthcare Investments and […]
Company pursuing additional application for JAN101 to treat COVID-19 complications Stable formulation and engineering for JAN101 will support Phase 2b PAD Study under the FDA’s Investigational New Drug (IND) #111703, expected to begin the first quarter of 2021 Scientific Advisory Board bolstered by expert additions LAS VEGAS, Sept. 22, 2020 /PRNewswire/ — JanOne […]
SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it is strengthening its leadership team with two appointments. William Whealon, Ph.D. has joined the company as Executive Vice President of […]
An experienced executive management team is leading the way in the FDA and CE-cleared cardiac monitoring products and services arena, using smart phones and cloud-based software technology ESCONDIDO, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — via NetworkWire — CB Scientific, Inc. (OTC: CBSC) (“CBSC” or the “Company”), a provider of […]
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the worldwide leader in advanced imaging for stroke, today announced a $25 million Series B round of funding by Lennertz & Co. Building on years of profitability, these additional funds will accelerate the company’s strategic growth initiatives around the world. Founded in 2011, RapidAI makes the […]
